Related Experiment Video
Updated: Sep 10, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Cognitive Screening with the Italian International HIV Dementia Scale in People Living with HIV: A Cross-Sectional
Maristella Belfiori1, Francesco Salis1,2, Sergio Angioni1
1Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy.
Insights
The Italian International HIV Dementia Scale (IHDS-IT) shows fair accuracy in detecting cognitive impairment in HIV patients, with a new optimal cut-off score of 9 or below. This tool aids in initial screening for HIV-associated neurocognitive disorders.
Area of Science:
- Neurology
- Infectious Diseases
- Psychiatry
Background:
- HIV-associated neurocognitive disorders (HANDs) remain a challenge despite combination antiretroviral therapy (cART).
- Neuropsychological assessments for HANDs diagnosis are resource-intensive.
- Brief screening tools are vital for initial evaluations of cognitive impairment in HIV patients.
Purpose of the Study:
- To assess the Italian version of the International HIV Dementia Scale (IHDS-IT).
- To evaluate the sensitivity and specificity of IHDS-IT in detecting cognitive impairment among HIV patients.
- To determine an optimal cut-off score for IHDS-IT in this population.
Main Methods:
- A cross-sectional study of 294 HIV patients (≥30 years) at the University of Cagliari.
- Cognitive function assessed using the Montreal Cognitive Assessment (MoCA) and IHDS.
- Statistical analyses included correlation, Receiver Operating Characteristic (ROC) analysis, and Youden J statistic.
Main Results:
- IHDS and MoCA scores showed a moderate positive correlation (rho = 0.411, p < 0.0001).
- ROC analysis identified an IHDS-IT cut-off of ≤9 with an Area Under the Curve (AUC) of 0.76, 71.7% sensitivity, and 67.2% specificity.
- A cut-off of ≤9 IHDS-IT correctly identified 73.1% of patients with MoCA scores < 23.
Conclusions:
- The IHDS-IT demonstrates fair diagnostic accuracy for cognitive impairment in HIV patients.
- A lower optimal cut-off (≤9) was identified compared to previous reports, potentially due to cohort characteristics.
- Further longitudinal studies are needed to validate these findings and the proposed cut-off.
Abstract:
Background: HIV-associated neurocognitive disorders (HANDs) continue to be a significant concern, despite the advancements in prognosis achieved through Combination Antiretroviral Therapy (cART). Neuropsychological assessment, recommended by international guidelines for HANDs diagnosis, can be resource-intensive. Brief screening tools, like the International HIV Dementia Scale (IHDS) and the Montreal Cognitive Assessment (MoCA), are crucial in facilitating initial evaluations. This study aims to assess the Italian IHDS (IHDS-IT) and evaluate its sensitivity and specificity in detecting cognitive impairment in HIV patients. Methods: This cross-sectional study involved 294 patients aged ≥30 years, evaluated at the Immunology Unit of the University of Cagliari. Cognitive function was assessed using the MoCA and IHDS. Laboratory parameters, such as CD4 nadir, current CD4 count, and HIV-RNA levels, were also collected. Statistical analyses included Spearman's correlation, Receiver Operating Characteristic analysis, and the Youden J statistic to identify the optimal IHDS-IT cut-off for cognitive impairment detection. Results: The IHDS and MoCA scores showed a moderate positive correlation (Spearman's rho = 0.411, p < 0.0001). ROC analysis identified an IHDS-IT cut-off of ≤9, yielding an Area Under the Curve (AUC) of 0.76, sensitivity of 71.7%, and specificity of 67.2%. At this threshold, 73.1% of patients with MoCA scores below 23 also presented abnormal IHDS scores, highlighting the complementary utility of both cognitive assessment instruments. Conclusions: The IHDS-IT exhibited fair diagnostic accuracy for intercepting cognitive impairment, with a lower optimal cut-off than previously reported. The observed differences may reflect this study cohort's demographic and clinical characteristics, including advanced age and long-lasting HIV infection. Further, longitudinal studies are necessary to validate these findings and to confirm the proposed IHDS cut-off over extended periods.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Intellectual Disability
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Alzheimer's Disease: Treatment